Tag: Central Sleep Apnea (CSA)
Study: ASV better for central apnea patients
January 24, 2018HME News Staff
SAN DIEGO - Patients with central sleep apnea who switch from positive airway pressure to adaptive servo ventilation therapy may be more adherent to therapy, according to a ResMed-funded study published in the Journal of Clinical Sleep Medicine. The study analyzed anonymous, aggregated data from the devices of 198,890 telemonitored patients with treatment-emergent central sleep apnea who started on PAP therapy. Researchers found 62.7% of patients were adherent on therapy while still on PAP; and 76.6%...
ResMed studies connect the dots on central sleep apnea
May 23, 2017HME News Staff
SAN DIEGO - People with treatment-emergent central sleep apnea (CSA) have a significantly greater risk of terminating CPAP therapy, according to a new ResMed-sponsored study presented on May 22 at the 2017 American Thoracic Society International Conference. Researchers found that 3.5% of patients had CSA during the first 90 days of therapy. ResMed says the study highlights the importance of regularly monitoring patients to support adherence to treatment, and diagnosing CSA early to minimize risk...
Study: ASV improves compliance
April 7, 2017HME News Staff
SAN DIEGO - Patients with obstructive sleep apnea who develop central sleep apnea are more compliant when they switch from CPAP to adaptive servo-ventilation, according to a new study. The study, sponsored by ResMed, analyzed anonymous, aggregated data from the devices of 198,890 telemonitored patients. It showed that patients who switched from CPAP to ASV went from 62.7% compliance to 76.6% compliance. “Achieving compliance through proper therapy usage is a well-recognized clinical goal in...
Patients in place for ResMed sleep apnea study
September 3, 2013HME News Staff
AMSTERDAM - More than 1,300 patients are signed up for a large study examining the outcomes of heart-failure patients using ResMed's PaceWave to treat central sleep apnea. ResMed announced Sept. 3 that enrollment is complete for the randomized, international study called SERVE-HF. The study will determine whether Resmed's Minute Ventilation ASV technology increases survival and reduces hospitalization of those with central sleep apnea. The technology monitors and stabilizes breathing patterns of...